NEW YORK (

TheStreet

) --

Hi-Tech Pharmacal

(Nasdaq:

HITK

) hit a new 52-week high Tuesday as it is currently trading at $37.55, above its previous 52-week high of $37.22 with 241,064 shares traded as of 3:35 p.m. ET. Average volume has been 180,900 shares over the past 30 days.

Hi-Tech Pharmacal has a market cap of $445.7 million and is part of the

health care

sector and

drugs

industry. Shares are up 41.8% year to date as of the close of trading on Monday.

TheStreet Recommends

Hi Tech Pharmacal Co., Inc., a specialty pharmaceutical company, engages in developing, manufacturing, and marketing generic and prescription, over-the-counter (OTC), and nutritional products in liquid and semi-solid dosage forms in the United States. The company has a P/E ratio of 9.3, below the average drugs industry P/E ratio of 9.8 and below the S&P 500 P/E ratio of 17.7.

  • Practice your HITK trading strategies and win cash in our stock game.

TheStreet Ratings rates Hi-Tech Pharmacal as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full

Hi-Tech Pharmacal Ratings Report

.

See all

52-week high stocks

or get investment ideas from our

investment research center

.

null